Association of Obesity with Renal Damage by Ultrasound in Patients Aged 30 to 59 Years from UMF 7 of Orizaba, Veracruz
Main Article Content
Abstract
Background: Obesity is defined as a chronic, multifactorial disease in which an increase in body fat causes adipose tissue dysfunction, leading to metabolic alterations. In Mexico, it presents a significant health problem and leads to multiple complications. A high BMI is associated with the development of proteinuria in people without kidney disease, as well as a low estimated glomerular filtration rate. Ultrasound (US) plays a fundamental role in the evaluation of morphological changes in the renal structure.
Objective: To demonstrate the association between obesity and kidney damage in patients aged 30 to 59 years at Family Medicine Unit No. 7 in Orizaba, Veracruz.
Materials and Methods: A longitudinal, analytical, and prospective study was conducted at Family Medicine Unit No. 7 in Orizaba, Veracruz, from November 2022 to May 2023, including all obese patients aged 30 to 59 years . Patients with a BMI > 30 were selected and classified into obesity grades. Glomerular filtration rate was calculated using serum creatinine levels and the CKD-EPI 2021. Renal ultrasound was performed to evaluate morphology. Frequency measures and percentages were used for qualitative variables, and measures of central tendency and dispersion were used for quantitative variables. The association was calculated using the chi-square test . The level of statistical significance was set at p < 0.05.
Results: Kidney damage was observed in 61 patients (20.3%) who were obese. Females predominated, with 163 (54.2%) patients, and the mean age was 42 years, with a median of 41 years, reflecting that the study population consisted of young adults.
Conclusions: This study does not show a correlation between obesity and ultrasound-detected kidney damage in patients aged 30 to 59 years at Family Medicine Unit No. 7 in Orizaba, Veracruz
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Bays HE, et al: Obesity Algorithm , presented by the Obesity Medicine Association . 2016-2017.
II. Pan American Health Organization. Obesity Prevention. Available at:
III. INEGI. Statistics on the occasion of World Obesity Day. Press release; 528/2020: pages 1-8.
IV. Veracruz State Health Secretariat. State Strategy for the Prevention and Control of Overweight, Obesity, and Diabetes. CENAPRECE
V. Diagnosis and treatment of overweight and exogenous obesity. Evidence and Recommendations Guide: Clinical Practice Guide. Mexico, CENETEC; 2018.
VI. Martín-Taboada M, Vila-Bedmar R, Medina-Gómez G. From Obesity to Chronic Kidney Disease : How Can Adipose Tissue Affect Renal Function ?. Nephron. 2021;145(6):609-613.
doi :10.1159/000515418.
VII. Kurniawan AL, Hsu CY, Rau HH, Lin LY, Chao JC. Association of kidney function-related dietary pattern , weight status , and cardiovascular risk factors with severity of impaired kidney function in middle-aged and older adults with chronic kidney disease : a cross-sectional population study . Nutr J. 2019 Apr 22;18(1):27.
doi :10.1186/s12937-019-0452-4.
VIII. Carretero Gómez, et al. Obesity is a chronic disease. Position statement of the Diabetes, Obesity and Nutrition Working Group of the Spanish Society of Internal Medicine (SEMI) for a person-centered approach with obesity. Rev Clin Esp. 2020. Pages 1-8. doi:10.1016/ j.rce.2020.06.008
IX. Ministry of Health. Overweight and obesity indicators. 2016.
X. Kovesdy CP, Furth S, Zoccali C. Obesity and kidney disease : Hidden consequences of the epidemic . Nephrology . 2017;37(4):360-369.
DOI: 10.1590/1414-431X20166075
XI. World Health Organization. Obesity and overweight. 2021. www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight
XII. Vries AP, et al. Fatty kidney : emerging role of ectopic lipid in obesity-related renal disease . Lancet Diabetes Endocrinol 2014; 2: 417–426,
doi : 10.1016/S2213-8587(14)70065-8.
XIII. D'Agati VD, Kaskel FJ, Falk RJ: Focal segmental glomerulosclerosis . N Engl J Med 2011; 365:2398–2411.
XIV. Correia-Costa L, Azevedo A, Caldas Afonso A. Childhood obesity and its impact on the kidney . Nephron. 2019;143(1):8-11.
doi :10.1159/000492826.
XV. Prague M, Morales E. The Fatty Kidney : Obesity and Renal Disease . Nephron 2017;136(4):273-276. doi :10.1159/000447674.
XVI. Okabayashi Y, et al. Glomerulopathy Associated With Moderate Obesity . Kidney Int Rep 2016;12;1(4):250-255.
doi : 10.1016/j.ekir.2016.08.006.
XVII. D'Agati VD, et al. Obesity-related glomerulopathy : clinical and pathologic characteristics and pathogenesis . Nat Rev Nephrol.2016;12(8):453–71.
XVIII. Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Consequences of Glomerular Hyperfiltration : The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity . Nephron . 2019;143(1):38-42.
doi :10.1159/000499486.
XIX. Denic A, et al. Single - Nephron Glomerular Filtration Rate in Healthy Adults . N Engl J Med . 2017;376(24):2349–57.
XX. Chen Y, et al. The inhibition of Nrf2 accelerates renal lipid deposition through suppressing the ACSL1 expression in obesity-related nephropathy . Ren Fail . 2019;41(1):821-831.
doi :10.1080/0886022X.2019.1655450.
XXI. Nehus E. Obesity and chronic kidney disease . Curr Opin Pediatrician 2018 Apr ;30(2):241-246.
doi : 10.1097/MOP.00000000000000586.
XXII. Prevention, Diagnosis and Treatment of Chronic Kidney Disease. Evidence and Recommendations Guide: Clinical Practice Guide. Mexico, CENETEC; 2019.
XXIII. Meola M, Samoni S, Petrucci I. Clinical scenarios in chronic kidney disease : vascular chronic disease . Contrib Nephrol 2016;188: 81–88.
XXIV. Petrucci I, Clementi A, Sessa C, Torrisi I, Meola M. Ultrasound and color Doppler applications in chronic kidney disease . Journal of Nephrology . 2018 Dec ;31(6):863-879. doi :10.1007/s40620-018-0531-1.
XXV. Boddi M. Renal Ultrasound (and Doppler Sonography ) in Hypertension : An Update . Adv Exp Med Biol. 2017;956:191 -208.
doi :10.1007/5584_2016_170.
XXVI. Ahmed S, Bughio S, Hassan M, Lal S, Ali M. Role of Ultrasound in the Diagnosis of Chronic Kidney Disease and its Correlation with Serum Creatine Level . Cureo. 2019; 12;11(3 ):e 4241.
doi : 10.7759/cureus.4241.
XXVII. Yaprak M, et al. Role of ultrasonographic chronic kidney disease score in the assessment of chronic kidney disease . Int Urol Nephrol . January 2017;49(1):123-131.
doi : 10.1007/s11255-016-1443-4.
XXVIII. Muftah Othman , Bisher Kawar , A. Meguid El Nahas , Influence of Obesity on Progression of Non- Diabetic Chronic Kidney Disease : A Retrospective Cohort Study:Nephron Clin Pract 2009;113:c16–c23.
XXIX. Yang P, et al. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice . Epub 2017;58(7):1417-1427. doi :10.1194/ jlr . M076216.
XXX. Hoi Shotaro , et al. Predictive Value of Cortical Thickness Measured by Ultrasonography for Renal Impairment : A Longitudinal Study in Chronic Kidney Disease . Journal of Clinical Medicine, 2018 7(12), 527–534. doi:10.3390/jcm7120527
XXXI. Lu S, Robyak K, Zhu Y. The CKD-EPI 2021 Equation and Other Creatinine-Based Race-Independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging . J Appl Lab Med . 2023 Sep 7;8(5):952-961. doi : 10.1093/ jalm /jfad047. PMID: 37534520.
XXXII. Pinto -Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE; PREVEND Study Group . A central body fat distribution es related to renal function impairment , even in lean subjects . Am J Kidney Dis . 2003 Apr;41(4):733-41.
doi : 10.1016/s0272-6386(03)00020-9.
PMID: 12666059.
XXXIII. Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS. Overweight , obesity , and the development of stage 3 CKD: the Framingham Heart Study . Am J Kidney Dis . 2008 Jul ;52(1):39-48. doi : 10.1053/j.ajkd.2008.03.003. Epub 2008 Apr 28. PMID: 18440684; PMCID: PMC2531220.
XXXIV. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O. Obesity and risk for chronic kidney failure . J Am Soc Nephrol . 2006 Jun ;17(6):1695-702. doi :10.1681/ASN.2005060638. Epub 2006 Apr 26. PMID: 16641153.
XXXV. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM. Association between body mass index and CKD in apparently healthy Men . Am J Kidney Dis . 2005 Nov ;46(5):871-80. doi : 10.1053/j.ajkd.2005.08.015. PMID: 16253727.